Pharma IT and AI – 2024 Health IT Predictions
Healthcare IT Today
JANUARY 8, 2024
While each company successfully gained FDA approvals, the current market acceptance for prescription digital therapeutics is low and improvements will take years. They will continue to run clinical trials to confirm their claims and value proposition but will not seek FDA approvals. Dave Latshaw, CEO at BioPhy 1.
Let's personalize your content